Zenex Animal Health acquires VievePharm to accelerate EU natural alternatives push
12 Mar 2026
With the European Union's Farm-to-Fork Strategy requiring a 50% cut in veterinary antibiotic sales by 2030, demand for science-backed natural alternatives is accelerating across European livestock markets.
Related Articles
Hamlet Protein's Erik Visser: 'M&A is about combining assumptions, not just assets'
3 Aug 2026
Science, People and the Long Game: Leading Phytobiotics Through a Period of Transformation
3 Aug 2026
Indonesia's Waingapu integrated shrimp estate targets 52,000 tonnes annually with Rp7.2 trillion investment
2 Aug 2026